Company profile
Inflamalps SA
Inflamalps is a company whose mission is to discover and develop novel medicines to treat inflammation with a focus on inflammatory diseases of the eye
Source: startup.ch
More news about Inflamalps SA
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". Register for more services
Partners
Contributors
